Foslinanib|TRX-818;TRX818

Cas No.:	1256037-60-1
Chemical Name:	2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin5-yl dihydrogen phosphate
Synonyms:	TRX-818;TRX818
SMILES:	P(OC1=C(OC)C=CC2=C1C(=O)C=C(C1=CC=CC(F)=C1)N2)(O)(O)=O
Formula:	C₁₆H₁₃FNO₆P
M.Wt:	365.253
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.

Cat. No.	Product name	Field of application
DC11087	TRX-818 sodium	TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation.
DC11086	Foslinanib	Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation.